Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Ann Oncol. 2019 Dec 1;30(12):1884-1901. doi: 10.1093/annonc/mdz411.

Authors

O Michielin¹, A C J van Akkooi², P A Ascierto³, R Dummer⁴, U Keilholz⁵, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Affiliations

¹ Department of Oncology, University Hospital Lausanne, Lausanne, Switzerland.
² Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
³ Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy.
⁴ Department of Dermatology, Skin Cancer Centre, University Hospital Zürich, Zürich, Switzerland.
⁵ Charité Comprehensive Cancer Centre, Charité-Universitätsmedizin Berlin, Berlin, Germany.

PMID: 31566661
DOI: 10.1093/annonc/mdz411

No abstract available

Keywords: clinical practice guidelines; cutaneous melanoma; diagnosis; treatment, follow-up.

MeSH terms

Follow-Up Studies
GTP Phosphohydrolases / genetics
Guidelines as Topic
Humans
Melanoma / diagnosis
Melanoma / epidemiology
Melanoma / genetics
Melanoma / therapy*
Membrane Proteins / genetics
Mutation / genetics
Proto-Oncogene Proteins B-raf / genetics
Risk Assessment*
Skin Neoplasms / diagnosis
Skin Neoplasms / epidemiology
Skin Neoplasms / genetics
Skin Neoplasms / therapy*
Tumor Suppressor Protein p53 / genetics

Substances

Membrane Proteins
TP53 protein, human
Tumor Suppressor Protein p53
BRAF protein, human
Proto-Oncogene Proteins B-raf
GTP Phosphohydrolases
NRAS protein, human

Supplementary concepts

Melanoma, Cutaneous Malignant